day trading software

This article is reprinted by permission from NextAvenue.org.

If you are like most people, when you hear the words estate planning, you probably think of writing a will, to explain who will get what you own when you die. The problem is, a will has little or nothing to do withyou. Its all about planning for someone else. In reality, estate planning is about much more than writing a will; its also about taking care ofyouwhile you are alive, should you become incapacitated and unable to make your own decisions.

day trading software: MannKind Corporation(MNKD)

Advisors’ Opinion:

  • [By James E. Brumley]

    When most investors think of diabetes stocks, names like Novo Nordisk A/S (ADR) (NYSE:NVO) and MannKind Corporation (NASDAQ:MNKD) come to mind. And well they should. Novo Nordisk is the biggest insulin company in the world, and while MannKind is relatively small, it’s a name that turns heads simply because it came up with an inhalable insulin that – after a slow start – is getting a little traction.

    In both cases though, the paradigm is the same one that was first used decades ago. That is, if a person isn’t making their own insulin, then it must be introduced externally. What if instead a diabetic’s glucose levels could be controlled by turning on the cells in their body responsible for processing that sugar? That’s the approach Cell MedX Corp (OTCMKTS:CMXC) is taking, using a relatively new but very compelling science.

    While chemical-based manufactured pharmaceuticals were largely the core of healthcare for well over the past century, it’s become clear that our bodies – right down to our cells – are also electrical in nature. Not only do they produce it, they need it to function properly. The FDA has even recently approved a therapeutic device that delivers mild electrical currents to and through an individual’s body as a means of treating pain. This “electromedicine” has also shown a certain degree of efficacy as a treatment for several illnesses, including cancer. Specifically, electrical currents have been demonstrated to force pleomorphic cancer microbes into hibernation, essentially making a cancerous cell a normal, healthy cell again. So, using an electrical current as a means of therapy for diabetics isn’t far-fetched at all. Indeed, it’s quite brilliant.

    As for how Cell MedX is using the idea, it’s actually quite simple. The device is called an eBalance. At first glance it just looks like another ordinary tablet computer. A closer inspection of the e-Balance device, however, makes it clear that it’s not just another tablet. It’

  • [By Sean Williams]

    Last summer, my mind was fully set on short-selling shares (i.e., betting they go down) of drugmaker MannKind (NASDAQ:MNKD). My investment thesis was pretty straightforward: MannKind was eventually going to seek bankruptcy protection.

  • [By Peter Graham]

    Small cap diabetes stock MannKind Corporation (NASDAQ: MNKD) reportedQ1 2017 earnings after the Thursday market close.The Companysnovel rapid-acting inhaled insulin therapy Afrezza has generally been a disappointment for investors with the stock havingelevated short interest of 38.86% according to Highshortinterest.com.

  • [By Lisa Levin]

    MannKind Corporation (NASDAQ: MNKD) shares were also up, gaining 24 percent to $6.59. H.C. Wainwright initiated coverage on MannKind with a Buy rating and a $7.00 price target.

  • [By WWW.MONEYSHOW.COM]

    MannKind Corp. (MNKD) has developed a drug, Afrezza, which is a new form of inhalable insulin that is proving to have many benefits over existing mealtime insulins for diabetics.  

  • [By Peter Graham]

    The Q4 2016 earnings report for troubled small cap diabetes stock MannKind Corporation (NASDAQ: MNKD) is scheduled for after the market closes Thursday (March 16th). So far,MannKind Corporations novel rapid-acting inhaled insulin therapy Afrezza has been a disappointment for investors; and if that doesnt start to change, theMNKD could soon run out of money. For that reason, the Company has elevated short interest of 36.43% according to Highshortinterest.com.

day trading software: Towerstream Corporation(TWER)

Advisors’ Opinion:

  • [By Lisa Levin]

    Towerstream Corporation (NASDAQ: TWER) shares were also up, gaining 9 percent to $3.49. Towerstream is scheduled to report Q2 financial results on August 9, 2016.

day trading software: Nord Anglia Education, Inc.(NORD)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested going long on small cap international school stock Nord Anglia Education Inc (NYSE: NORD):

  • [By Lisa Levin]

    Nord Anglia Education Inc (NASDAQ: NORD) shares shot up 19 percent to $32.83 after the company agreed to be acquired for $32.50 per share in cash.

day trading software: CIRCOR International, Inc.(CIR)

Advisors’ Opinion:

  • [By Lisa Levin]

    CIRCOR International, Inc. (NYSE: CIR) was down, falling around 15 percent to $60.91. CIRCOR reported Q4 adjusted earnings of $0.48 per share on revenue of $158 million. Stifel Nicolaus downgraded Circor from Buy to Hold.

day trading software: Gartner, Inc.(IT)

Advisors’ Opinion:

  • [By Lisa Levin]

    CEB Inc. (NYSE: CEB) shares were also up, gaining 21 percent to $74.90 after Gartner Inc (NYSE: IT) announced plans to acquire the company for $2.6 billion in cash and stock.

day trading software: Signet Jewelers Limited(SIG)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Signet Jewelers Limited (NYSE: SIG), which rose roughly 9% to $52.52. The stocks 52-week range is $46.09 to $101.46. Volume was nearly 5 million on the day compared to the average of 1.8 million.

  • [By Peter Graham]

    A long term performance chart shows shares of Tiffany & Co and small cap Blue Nile Inc (NASDAQ: NILE) nowback in positive territory and trending up while Signet Jewelers Ltd (NYSE: SIG) has outperformedbut that outperformancestarted falling off late last year:

  • [By WWW.THESTREET.COM]

    Earnings of note in the coming week include Analogic (ALOG) and Ascena Retail (ASNA) on Monday; Bojangles (BOJA) , H&R Block (HRB) , and Dick’s Sporting Goods (DKS) , Michaels (MIK) , and Urban Outfitters (URBN) on Tuesday; Ciena (CIEN) , Bankrate (RATE) , Express (EXPR) , Vera Bradley (VRA) , and Bob Evans Farms (BOBE) on Wednesday; El Pollo Loco (LOCO) , Hugo Boss (BOSSY) , Party City (PRTY) , Signet Jewelers (SIG) , and Verifone Systems (PAY) on Thursday; and Kirkland’s (KIRK) , and Vail Resorts (MTN) on Friday.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Signet Jewelers Limited (NYSE: SIG) which jumped 8.8% to $70.06. The gain was following news that the company had a solid earnings report. The stocks 52-week range is $62.10 to $125.45. Volume was 7.48 million which is well above the daily average of around 1.69 million shares.

Leave a Reply

Your email address will not be published. Required fields are marked *